Results 201 to 210 of about 32,431 (267)
HPA/HPG axes dysfunction: assessing the interrelations between diminished ovarian reserve and mental health. [PDF]
J Ovarian ResDing Z +5 more
europepmc +1 more source
Sex differences in response to longevity interventions. [PDF]
Ageing Res RevHajdarovic KH, Riddle NC, Webb AE.
europepmc +1 more source
The Influence of Different Light Spectra on Broiler Chicken Endocrine Systems and Productivity. [PDF]
Animals (Basel)Galan L, Solcan G, Solcan C.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Luteinizing Hormone-Releasing Hormone in Human Pituitary Blood
Obstetrical & Gynecological Survey, 1978✓ Luteinizing hormone (LH) and LH-releasing hormone (LHRH) were measured by radioimmunoassay in blood samples collected from the pituitary gland during transsphenoidal surgery in 19 patients. Detectable levels of LHRH were present in 12 patients. Wide fluctuations of LHRH were seen in sequential samples collected at 10-minute intervals, suggesting a ...
J L, Antunes +3 more
openaire +2 more sources
Modelling the Pituitary Response to Luteinizing Hormone‐Releasing Hormone
Journal of Neuroendocrinology, 2004AbstractThe pituitary response to luteinizing hormone‐releasing hormone (LHRH) is steroid‐dependent and varies throughout the reproductive cycle, but the rapid rise in pituitary sensitivity on the day of the ovulation‐inducing LH surge is due to a ‘self‐priming’ effect of exposure to LHRH that results in a potentiation of pituitary responsiveness 35–40
S, Scullion, D, Brown, G, Leng
openaire +2 more sources
Effects of cholinergic stimulation on pituitary hormone release
Psychoneuroendocrinology, 1982Abstract Physostigmine was infused into human volunteers to assess the effect of central cholinergic stimulation on memory and on neuroendocrine function. Methscopolamine bromide, a peripheral anticholinergic agent, was given simultaneously. The lower dose of physostigmine (1.0 mg) produced no change in AVP, cortisol, melatonin, GH or LH in those ...
B M, Davis +5 more
openaire +2 more sources
The Journal of Clinical Endocrinology & Metabolism, 1983
In vitro evidence suggests that calcium is involved in the release of anterior pituitary hormones. Therefore, we studied the effect of the slow calcium channel blocker or calcium antagonist nifedipine on the FSH and LH responses to LRH and the TSH and PRL responses to TRH in vivo. Nine normal male subjects were studied on two occasions, and nifedipine
Struthers, A. D. +4 more
openaire +3 more sources
In vitro evidence suggests that calcium is involved in the release of anterior pituitary hormones. Therefore, we studied the effect of the slow calcium channel blocker or calcium antagonist nifedipine on the FSH and LH responses to LRH and the TSH and PRL responses to TRH in vivo. Nine normal male subjects were studied on two occasions, and nifedipine
Struthers, A. D. +4 more
openaire +3 more sources
Clinical Endocrinology, 1976
SummaryIntrajugular administration of LHRH (0.6 and 1.2 μg) in hypophysectomized rats which received renal grafts of anterior pituitary induced a small but significant rise in plasma GH 5 and 10 min post‐treatment. LHRH, at the same dose levels, was ineffective in weight‐matched intact controls.
Panerai A. E. +5 more
openaire +3 more sources
SummaryIntrajugular administration of LHRH (0.6 and 1.2 μg) in hypophysectomized rats which received renal grafts of anterior pituitary induced a small but significant rise in plasma GH 5 and 10 min post‐treatment. LHRH, at the same dose levels, was ineffective in weight‐matched intact controls.
Panerai A. E. +5 more
openaire +3 more sources